<DOC>
	<DOC>NCT00219700</DOC>
	<brief_summary>To determine the safety and efficacy of 3 x 800 mg/day IBU-PC assessed by endoscopy and incidence of adverse events</brief_summary>
	<brief_title>Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>moderate osteoarthritis in the hip and/or knee requiring chronic pain medication others per protocol sensitivity to NSAIDs and lecithin hypertension history of GI and other specific problems use of medications and other criteria per the protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>NSAID-PC</keyword>
	<keyword>IBU-PC</keyword>
</DOC>